{"id":"W2925781938","doi":"10.1016/j.lungcan.2019.02.021","title":"Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"MSD K.K.; Chugai Pharmaceutical; Novartis Pharmaceuticals Canada; Kyowa Hakko Kirin; Eli Lilly Japan; Boehringer Ingelheim","keywords":"Osimertinib; Medicine; T790M; Lung cancer; Internal medicine; Oncology; Epidermal growth factor receptor; Cancer; Erlotinib; Gefitinib","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003211002,0.0002291896,0.0007119868,0.0002662714,0.0003020767,0.0004932995,0.0002468755,0.0004351101,0.002165666],"category_scores_gemma":[0.0005221218,0.00008929355,0.0006104955,0.000196296,0.0001977184,0.0003449759,0.0001430939,0.001233042,0.0005442986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007381577,"about_ca_system_score_gemma":0.0003706789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008774466,"about_ca_topic_score_gemma":0.002928981,"domain_scores_codex":[0.9998548,0.00002176914,0.00001284088,0.00002477246,0.00002779821,0.00005794982],"domain_scores_gemma":[0.9998646,0.00002834576,0.00002119712,0.00002376585,0.00001519731,0.00004677929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.05688499,0.006671152,0.02390548,0.0006946374,0.001190479,0.0128859,0.0003920352,0.004539508,0.12688,0.002138228,0.01651863,0.747299],"study_design_scores_gemma":[0.02940124,0.1429687,0.2928505,0.0004631428,0.002380914,0.06232651,0.0008484816,0.02483943,0.18309,0.005043926,0.2555139,0.0002732833],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798314,0.006904923,0.0009236543,0.00119202,0.0004880188,0.0002401119,0.0004209518,0.0001189428,0.009879966],"genre_scores_gemma":[0.9940935,0.001090781,0.0004164087,0.000445806,0.00007636347,0.00005692815,0.000461585,0.00001975081,0.003339027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002165666,"threshold_uncertainty_score":0.007244885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01328733990522649,"score_gpt":0.3352145367677815,"score_spread":0.3219271968625549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}